Clinical trial
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other…
NCT00453206 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00453206 |
|---|---|
| Title | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases |
| Official title | Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Patients With Hematological Diseases |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes |
| Intervention type | Procedure |
| Interventions | allogeneic bone marrow transplantation, allogeneic hematopoietic stem cell transplantation, nonmyeloablative allogeneic hematopoietic stem cell transplantation, peripheral blood stem cell transplantation |
| Enrollment | 66 |
| Start date | Feb 1, 2007 |
| Primary completion | Feb 1, 2014 |
| Completion | Aug 1, 2014 |
| First posted | Mar 28, 2007 |
| Last update posted | Sep 10, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: